Last reviewed · How we verify
NCT07028255
Effectiveness of Qualia Testosterone Supplementation on Testosterone Levels
NA trial testing Qualia Testosterone in Testosterone in 60 participants. Not yet recruiting.
1 September 2025
Quick facts
| Lead sponsor | Qualia Life Sciences |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | other |
| Enrollment | 60 |
| Start date | 1 July 2025 |
| Primary completion | 1 September 2025 |
| Estimated completion | 1 October 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Qualia Testosterone
- Placebo
Conditions studied
- Testosterone — all drugs for Testosterone →
Sponsor
Qualia Life Sciences
Who can join
Adults 28 to 65, male only, with Testosterone. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a randomized, double-blind, placebo-controlled parallel trial designed to assess the efficacy of Qualia Testosterone, a novel dietary supplement, in adult males aged 28 to 65 experiencing symptoms associated with testosterone deficiency. Approximately 60 participants will be randomized to receive either Qualia Testosterone (2 capsules daily) or a matched placebo for 21 days, with dosing administered each morning. The study's primary outcomes are changes in total testosterone, free testosterone (via dialysis), and dihydrotestosterone levels from baseline to Week 3. Secondary outcomes include changes in Aging Male Symptoms Scale scores-encompassing psychological, somatic, and sexual domains-as well as safety and tolerability. Blood samples will be collected in a laboratory setting, while symptom and safety assessments will be completed electronically at home.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07028255
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Testosterone
Currently open trials in the same condition.
- NCT07256639 — Evaluating Heart & Soil's Whole Package on Men's Health · NA · recruiting
- NCT07076771 — Serum Testosterone Level on Angiographic Complexity of Coronary Lesions in Premature Ischemic Egyptian Males · recruiting
Other Qualia Life Sciences trials
Trials by the same sponsor.
- NCT07361757 — Qualia Perimenopause Efficacy and Tolerability Study: An Open-label 3-Arm Trial · NA · not yet recruiting
- NCT07285109 — The Impact of Qualia Vitamin C+ on Blood Vitamin C Levels · NA · recruiting
- NCT07221955 — The Impact of Qualia Gluthathione+ on Blood Glutathione Levels · NA · not yet recruiting
- NCT07132801 — Comparison of Two Qualia NAD⁺ Formulations on Intracellular NAD⁺ Levels · NA · not yet recruiting
- NCT07156526 — Impact of Two Iron Formulations on Iron Biomarkers and Quality of Life · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07028255 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Qualia Life Sciences
- Last refreshed: 19 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07028255.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing